Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bespoke Extracts (BSPK) Cash & Equivalents (2017 - 2025)

Bespoke Extracts' Cash & Equivalents history spans 9 years, with the latest figure at $16743.0 for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 21.93% year-over-year to $16743.0; the TTM value through Sep 2025 reached $16743.0, down 21.93%, while the annual FY2024 figure was $60305.0, 812.74% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $16743.0 at Bespoke Extracts, up from $1363.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $501560.0 in Q1 2021 and bottomed at $1363.0 in Q2 2025.
  • The 5-year median for Cash & Equivalents is $19094.0 (2024), against an average of $52151.0.
  • The largest YoY upside for Cash & Equivalents was 27522.92% in 2021 against a maximum downside of 97.56% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $6295.0 in 2021, then surged by 288.13% to $24433.0 in 2022, then plummeted by 72.96% to $6607.0 in 2023, then skyrocketed by 812.74% to $60305.0 in 2024, then tumbled by 72.24% to $16743.0 in 2025.
  • Per Business Quant, the three most recent readings for BSPK's Cash & Equivalents are $16743.0 (Q3 2025), $1363.0 (Q2 2025), and $30365.0 (Q1 2025).